Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-06T13:20:25.922Z Has data issue: false hasContentIssue false

A longitudinal etiologic model for symptoms of anxiety and depression in women

Published online by Cambridge University Press:  11 April 2011

K. S. Kendler*
Affiliation:
Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, VA, USA Department of Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
C. O. Gardner
Affiliation:
Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
*
*Address for correspondence: K. S. Kendler, M.D., Virginia Institute for Psychiatric and Behavioral Genetics of VCU, Box 980126, Richmond, VA 23298-0126, USA. (Email: kendler@vcu.edu)
Rights & Permissions [Opens in a new window]

Abstract

Background

Designed as state measures to monitor treatment response, symptoms of anxiety and depression (SxAnxDep) also have trait-like characteristics. No comprehensive etiologic model for SxAnxDep has illuminated the inter-relationship between their state- and trait-like characteristics, while including key predictor variables.

Method

In a prospective three-wave study of 2395 female twins from the Virginia Adult Twin Study of Psychiatric and Substance Use Disorders (VATSPSUD), we examined, using structural equation modeling, how genes, childhood and past-year environmental stressors, personality and episodes of major depression (MD) and generalized anxiety disorder (GAD) influence SxAnxDep.

Results

The best-fit model, which explained 68–74% of the variance in SxAnxDep, revealed two etiologic pathways. Stable levels of SxAnxDep resulted largely from neuroticism, which in turn was influenced by genetic and early environment risk factors. Occasion-specific influences resulted from stressful events mediated through episodes of MD or GAD. These two pathways, which had approximately equal influences on levels of SxAnxDep, were substantially correlated because the genetic, early environmental and personality factors that impacted on stable symptom levels also predisposed to event exposure and disorder onset. No significant interaction was seen between the two pathways.

Conclusions

SxAnxDep in women in the general population arise from two inter-related causal pathways. The first, the ‘trait-like’ pathway, reflects genetic and early environmental risk factors, and is mediated largely through personality. The second pathway is mediated through episodes of MD and GAD, and is the result of both recent environmental adversities and trait-like factors that influence event exposure and the probability of disorder onset.

Information

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2011
Figure 0

Fig. 1. Parameter estimates for our best-fit model for symptoms of anxiety and depression (SxAnxDep) measured over three waves in female twins from the Virginia Adult Twin Study of Psychiatric and Substance Use Disorders (VATSPSUD). Rectangles reflect observed variables and ovals represent latent variables. Loadings on the latent variables (except for ‘Stable Component – Symptoms of Anxiety and Depression’) are given in Table 1. Single-headed arrow path coefficients represent standardized partial regression coefficients. Two-headed arrows represent correlation coefficients.

Figure 1

Table 1. Factor loadings on the latent variables in the best-fit model

Figure 2

Fig. 2. Parameter estimates for our best-fit model for symptoms of anxiety and depression (SxAnxDep) measured over three waves in female twins from the Virginia Adult Twin Study of Psychiatric and Substance Use Disorders (VATSPSUD) with the temporally stable pathway estimates highlighted.

Figure 3

Fig. 3. Distribution of the average standardized score across the four Symptom Checklist (SCL) scales making up our symptoms of anxiety and depression (SxAnxDep) measure in subjects reporting (lower section) and not reporting (upper section) being in a current episode of major depression (MD) or generalized anxiety disorder (GAD).